Clinical Trial Update: A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease. [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7486967 in participants with early Parkinson's disease has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RO7486967

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED